|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $27,100,276 | $32,965,736 | $44,161,641 | $56,735,120 | $40,004,384 | $44,329,061 | $44,447,589 |
| Streptomycins & their derivs.; salts thereof | $883,543 | $1,084,836 | $699,254 | $990,325 | $990,180 | $930,686 | $1,489,812 |
| Tetracyclines & their derivs.; salts thereof | $13,601,122 | $15,422,249 | $13,665,344 | $30,253,323 | $17,619,653 | $23,495,207 | $36,224,940 |
| Chloramphenicol & its derivs.; salts thereof | $4,603,333 | $3,054,008 | $3,909,075 | $4,778,801 | $6,214,066 | $3,964,044 | $6,598,772 |
| Erythromycin & its derivs.; salts thereof | $6,850,318 | $8,325,285 | $6,418,075 | $8,052,408 | $5,496,601 | $6,393,449 | $7,338,406 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $130,721,557 | $146,230,434 | $128,366,418 | $179,522,485 | $182,436,079 | $185,969,891 | $193,773,918 |
| Total | $183,760,149 | $207,082,548 | $197,219,807 | $280,332,462 | $252,760,963 | $265,082,338 | $289,873,437 |
|
|
